Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synthetic LT4/LT3 combination therapy versus desiccated thyroid extract in symptomatic hypothyroidism
2019-000239-21Phase 4Terminated
- Sponsor
- University of Copenhagen
- Start
- May 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of thyroid, porcine, levothyroxine sodium and liothyronine in hypothyroidism (2 arms), sponsored by University of Copenhagen. Primary endpoint: Preference of DTE vs L-T4/L-T3 combination therapy. Started May 2019; status: terminated.
02
Drugs
thyroid, porcinelevothyroxine sodiumliothyronine
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on 2019-000239-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000239-21.